We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.16%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEA icon
776
Lear
LEA
$6.35B
$830K 0.02%
5,782
+40
+0.7% +$5.28K
AN icon
777
AutoNation
AN
$7.19B
$826K 0.02%
+5,018
New +$696K
PGR icon
778
Progressive
PGR
$122B
$820K 0.02%
6,194
+1,223
+25% +$164K
MD icon
779
Pediatrix Medical
MD
$2.17B
$819K 0.02%
57,619
-15,738
-21% -$221K
MELI icon
780
Mercado Libre
MELI
$96.3B
$819K 0.02%
691
+173
+33% +$218K
ATR icon
781
AptarGroup
ATR
$8.69B
$813K 0.02%
7,013
+244
+4% +$28.6K
MBB icon
782
iShares MBS ETF
MBB
$38.9B
$811K 0.02%
+8,699
New +$818K
NTR icon
783
Nutrien
NTR
$31.5B
$810K 0.02%
13,716
-4,290
-24% -$273K
APLS
784
DELISTED
Apellis Pharmaceuticals
APLS
$810K 0.02%
8,888
+1,548
+21% +$134K
FVC icon
785
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$105M
$809K 0.02%
24,069
+442
+2% +$14.5K
TOL icon
786
Toll Brothers
TOL
$14.1B
$808K 0.02%
+10,224
New +$686K
ATI icon
787
ATI
ATI
$26.3B
$806K 0.02%
18,219
+669
+4% +$25.6K
BST icon
788
BlackRock Science and Technology Trust
BST
$1.66B
$801K 0.02%
23,270
+6
+0% +$194
COIN icon
789
Coinbase
COIN
$39.7B
$796K 0.02%
11,130
-1,685
-13% -$101K
DY icon
790
Dycom Industries
DY
$12.6B
$796K 0.02%
+7,003
New +$692K
DES icon
791
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$794K 0.02%
27,590
-11
-0% -$307
VONV icon
792
Vanguard Russell 1000 Value ETF
VONV
$20.9B
$793K 0.02%
11,458
-1,500
-12% -$101K
NEA icon
793
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.37B
$792K 0.02%
72,470
+13,486
+23% +$148K
FSLR icon
794
First Solar
FSLR
$25.2B
$792K 0.02%
4,166
+1,090
+35% +$216K
INFL icon
795
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.51B
$792K 0.02%
25,896
-1,225
-5% -$37.5K
BOND icon
796
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.43B
$791K 0.02%
8,635
-265
-3% -$24.4K
FDEC icon
797
FT Vest US Equity Buffer ETF December
FDEC
$1.34B
$789K 0.02%
21,895
-21,334
-49% -$734K
CGCP icon
798
Capital Group Core Plus Income ETF
CGCP
$8.4B
$786K 0.02%
35,329
+8,686
+33% +$196K
ES icon
799
Eversource Energy
ES
$26.9B
$785K 0.02%
11,071
+225
+2% +$16.8K
PD icon
800
PagerDuty
PD
$855M
$782K 0.02%
+34,800
New +$967K

Similar funds

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.